Our History

The story of a dream come true

The history of Cantabria Labs is the story of a dream come true thanks to the effort, dedication and entrepreneurship of the people and family that make up this pharmaceutical company with a close spirit but an important international dimension.


1989

  • Difur: first steps in dermatology

1994

  • Acquisition and strategic reorientation of 100% of Industrial Farmacéutica Cantabria.
  • Agreement for the distribution of Neostrata in Spain and development of its products adapted to some markets.

1995

  • Discovery and patent of oral photoprotection in collaboration with Havard University.
  • AM3® patented technology

1996

 

  • Creation of Isolagen Europe, company specialised in high-tech autologous cell cultures.

2001

  • The international division is born.
  • Creation of the export department due to growing demand.

2002

  • Divestment in generic products (UR) and release of resources to centre the activity on dermatology.

2003

  • Incorporation of Difa Cooper, Italian laboratory established in 1959, and expansion of the vademecum with state-of-the-art ingredients, technologies and products.

2006

  • Acquisition of the Brazilian dermatological company Melora do Brasil S.A.
  • Divestment in the general pharmaceutical business and acquisition of new rights and patented technologies in dermatology such as RetinSphere and RTF1.

2007

  • Acquisition of 95% shares of HDP, the Belgian dermal-cosmetic distribution company.
  • Creation of Gourmetceuticals LLC, to enter the American market of ingredients and foodstuffs for human and veterinary consumption.

2008

  • Agreement with Ferndale Labs: increase of activities in North America and consolidation of Heliocare® Oral.
  • Introduction of Fernblock® in the American market.

2009

  • Launch of the patent of a new molecule to contribute to stem cell regeneration.
  • Consolidation in the Iberian peninsula with Cantabria Labs Portugal.
  • Purchase of the dermatology portfolio of Sirton Medicare

2011

  • Purchase of rights of new technology for alopecia, acne, hyperpigmentation and photoaging.

2012

  • Implementation of the RIO product of Operative Excellence, based on the study and improvement of all the operating processes of the company.
  • Purchase of the trichology portfolio from Fitológica.
  • RetinSphere® patented technology.

2013

  • Diversification of the offer of products and solutions with optimisation of the use of its own ingredients in special medical foodstuffs.
  • Specialisation in products for clinical nutrition (oncology, radiotherapy and geriatrics) with Nutrición Médica.

2014

  • Investment of Prokrea BCN, biotech company specialised in pharmaceutical products for fertility treatment.
  • Participation in Cre100do, initiative by the Bankinter Innovation Foundation, for growth potential.
  • Reincorporation of Inmunoferon® to the vademecum after eight years of exclusion.

2015

  • Introduction in Spain of ZO Skin Health, medical cosmetics.
  • Creation of Cantabria Labs Morocco and rollout of the development and expansion plan  in the African market.
  • Creation of a specialised sales network for the pharmacy channel.

2016

  • Diversification to reach paediatrics (Inmunoferon) and otolaryngology.
  • 20 year licensing agreement with Krymi Laboratori.
  • Approval for the production of NSF nutraceutical supplements.
  • Entry in Histocell, a specialist company in regenerative medicine and cell therapy.
  • Purchase of 60% of Avance Cosmetics and opening of a new retail channel.

2017

  • Launch of Edafence® patented technology based on the plant Deschampsia antartica.
  • Agreement with the Massachusetts Institute of Technology (MIT) to sponsor and promote bio dermal innovation programmes.
  • Start of works of the new innovation and eco-sustainable production centre in Cantabria.
  • Birth of Cantabria Labs Mexico to increase presence in the American market.
  • Creation of Cantabria Labs China, strategic market for growth in healthcare.

2018

  • Alliance between Capsa Food and Cantabria Labs Nutrición Médica to launch clinical nutrition formulas.
  • Agreement with Stangest to enter the pet care market.
  • Award to Cantabria Labs for over 25 years working in dermatology presented by the AEDV.
  • Adoption of a new corporate identity: Cantabria Labs.
  • Appointment of Susana Rodríguez as new CEO of Cantabria Labs and Juan Matji as President of the Board of Directors.

2019

  • Inauguration of the new innovation and eco sustainable production centre La ConchaTo find out more, click here

Lo último del Área de Comunicación

News 30 Oct 2020

Cantabria Labs acquires the ELANCYL body care brand from Pierre Fabre

Spanish pharmaceutical company Cantabria Labs has bought ELANCYL, the expert body care brand, after reaching an acquisition agreement with the...
rafa-nadal-cantabrialabs
News 12 May 2020

Rafa Nadal with HELIOCARE: “Give your all for what matters never to the sun”

• The Spanish tennis ace is the face of the “Give Your All for What Matters never to the Sun”...
News 7 May 2020

Cantabria Labs collaborates in the Covid-19 research project of Alcalá University

The study led by the University Professor Melchor Álvarez de Mon, seeks to identify precisely which medicines and what treatments will...